Plain-English translation of NCT07201363 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is looking at blood markers (substances in your blood that show inflammation and scarring) in patients who are having a minimally invasive aortic valve replacement procedure. The researchers want to understand whether these blood markers can predict which patients might develop heart rhythm problems after the procedure — a complication that currently affects many patients but is difficult to anticipate ahead of time.
Heart rhythm problems are a common concern after aortic valve replacement, and doctors currently have no reliable way to predict which patients will experience them. If blood markers can help identify high-risk patients before or after the procedure, doctors could monitor those patients more closely or adjust their care plan to prevent serious complications.
You likely qualify if…
You likely don't qualify if…
You would undergo the scheduled aortic valve replacement procedure as planned. Before the procedure and at a follow-up visit about three months later, researchers would collect blood samples to measure inflammation and scarring markers. Your heart rhythm would be monitored using standard electrocardiograms (ECG) during your hospital stay and at the follow-up appointment, and researchers would track whether you develop any heart rhythm problems during this period.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
Croatia